Cardiac Surgery-LAA Occlusion/Excision: Recommendation e221ĥ.1. Percutaneous Approaches to Occlude the LAA e221Ĥ.4.2. Nonpharmacological Stroke Prevention e221Ĥ.4.1. Interruption and Bridging Anticoagulation e220Ĥ.4. Considerations in Selecting Anticoagulants e218Ĥ.3. New Target-specific Oral Anticoagulants e216Ĥ.2.2.3. Risk Stratification Schemes (CHADS 2, CHA 2DS 2-VASc, and HAS-BLED) e213Ĥ.2.2.2. Selecting an Antithrombotic Regimen-Balancing Risks and Benefits e212Ĥ.1.1.1. Risk-Based Antithrombotic Therapy: Recommendations e211Ĥ.1.1. Rhythm Monitoring and Stress Testing ……….e210Ĥ.1. Clinical History and Physical Examination e210ģ.1.3. Basic Evaluation of the Patient With AF e210ģ.1.1. Risk Factors and Associated Heart Disease e209ģ.1. The Renin-Angiotensin-Aldosterone System e209Ģ.2.3.4. Inflammation and Oxidative Stress e209Ģ.2.3.3. Atrial Tachycardia Remodeling e209Ģ.2.3.2. Pathophysiological Mechanisms e209Ģ.2.3.1. Role of the Autonomic Nervous System e209Ģ.2.3. Electrophysiological Mechanisms e208Ģ.2.2.3. Atrial Structural Abnormalities e207Ģ.2.2. ![]() Mechanisms of AF and Pathophysiology e207Ģ.2.1. Atrial Flutter and Macroreentrant Atrial Tachycardia e206Ģ.2. Definitions and Pathophysiology of AF e205Ģ.1.1.2. ![]() Organization of the Writing Committee e203Ģ.1.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |